Screening for inborn errors of metabolism using gas chromatography-mass spectrometry

K Xu1, L Wang, H Cai

  • 1Capital Institute of Pediatrics, Beijing, PR China. xdcui@public.intercom.com.cn

Insights

Newborn screening for inborn errors of metabolism (IEM) is crucial. Gas chromatography-mass spectrometry (GC-MS) successfully identified 51 IEM cases, with galactosemia, phenylketonuria, and methylmalonic acidemia being most common.

Area of Science:

  • Medical Genetics
  • Biochemistry
  • Pediatrics

Background:

  • Newborn screening for inborn errors of metabolism (IEM) remains an underdeveloped area in China.
  • Gynecologists and pediatricians face challenges in implementing and managing IEM screening programs.

Purpose of the Study:

  • To evaluate the effectiveness of gas chromatography-mass spectrometry (GC-MS) for newborn screening of IEM in China.
  • To identify the prevalence and types of IEM among screened newborns.

Main Methods:

  • Utilized advanced gas chromatography-mass spectrometry (GC-MS) for IEM screening.
  • Collaborated with the Matsumoto Institute of Life Science (MILS), Japan.
  • Screened 393 patients, diagnosing 51 cases of IEM.

Main Results:

  • Successfully diagnosed 51 cases of IEM out of 393 screened patients.
  • Identified galactosemia, phenylketonuria, and methylmalonic acidemia as the most frequent IEM disorders.
  • Demonstrated high effectiveness of drug and/or diet therapy for most diagnosed cases.

Conclusions:

  • GC-MS is an effective method for newborn screening of IEM in China.
  • Early diagnosis and appropriate treatment significantly improve outcomes for IEM patients.
  • Further development and implementation of newborn screening programs are essential in China.

Related Concept Videos

Gas Chromatography–Mass Spectrometry (GC–MS)01:14

Gas Chromatography–Mass Spectrometry (GC–MS)

Gas chromatography–mass spectrometry (GC–MS) is the combination of analytical techniques of gas chromatography and mass spectrometry in a single instrument for analyzing a mixture of compounds. The gas chromatograph separates the compounds in the mixture, and the mass spectrometer analyzes each compound separately to determine the molecular masses and molecular structures.
A gas chromatograph consists of a long, narrow capillary column with a polysiloxane coating on the inner wall. The coating...
Gas Chromatography: Introduction01:13

Gas Chromatography: Introduction

Gas chromatography (GC) is a technique for separating and analyzing volatile compounds in a sample. Its primary purpose is to identify and quantify components in complex mixtures, making it essential in fields such as environmental analysis, pharmaceuticals, and petrochemicals. GC is also called vapor-phase chromatography (VPC) or gas-liquid partition chromatography (GLPC).
In GC,  a sample is vaporized and mixed with an inert carrier gas (the mobile phase), which transports it through a column.
Mass Spectrometry: Complex Analysis01:21

Mass Spectrometry: Complex Analysis

Mass spectrometry is an important technique for the identification of pure compounds. However, it has some limitations for the analysis of complex mixtures, often due to excessive fragmentation making the spectrum too complicated to decipher. Mass spectrometry can be combined with suitable separation methods in sequence, forming hyphenated methods, which are useful in the analysis of complex mixtures.
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
Gas Chromatography: Overview of Detectors01:13

Gas Chromatography: Overview of Detectors

Detectors in gas chromatography (GC) help identify and quantify the components of a mixture by translating chemical properties into measurable signals, which are displayed on a chromatogram. Detectors can be categorized into two main types: destructive and non-destructive.
A non-destructive detector allows a sample to be analyzed without altering or consuming it, meaning the sample can be collected after detection for further analysis. Examples include thermal conductivity detectors and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...